These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 28982951

  • 21. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.
    Iqbal NJ, Boey A, Park BJ, Brandt ME.
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):348-50. PubMed ID: 18707841
    [Abstract] [Full Text] [Related]

  • 22. Benefit of polyhexamethylene biguanide in Fusarium keratitis.
    Behrens-Baumann W, Seibold M, Hofmüller W, Walter S, Haeberle H, Wecke T, Tammer I, Tintelnot K.
    Ophthalmic Res; 2012 Nov; 48(4):171-6. PubMed ID: 22710976
    [Abstract] [Full Text] [Related]

  • 23. Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of Fusarium and Aspergillus Isolates from Corneal Scrapings.
    Manikandan P, Abdel-Hadi A, Randhir Babu Singh Y, Revathi R, Anita R, Banawas S, Bin Dukhyil AA, Alshehri B, Shobana CS, Panneer Selvam K, Narendran V.
    Biomed Res Int; 2019 Nov; 2019():6395840. PubMed ID: 30800674
    [Abstract] [Full Text] [Related]

  • 24. Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis.
    Lalitha P, Shapiro BL, Loh AR, Fothergill AW, Prajna NV, Srinivasan M, Oldenburg CE, Quigley DA, Chidambaram JD, McLeod SD, Acharya NR, Lietman TM.
    Br J Ophthalmol; 2011 May; 95(5):744-5. PubMed ID: 21030412
    [No Abstract] [Full Text] [Related]

  • 25. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988
    [Abstract] [Full Text] [Related]

  • 26. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
    Xu Y, Pang GR, Zhao DQ, Gao CW, Zhou LT, Sun ST, Wang BL, Chen ZJ.
    Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
    [Abstract] [Full Text] [Related]

  • 27. In vitro comparison of the efficacies of natamycin and silver nitrate against ocular fungi.
    Xu Y, Pang G, Gao C, Zhao D, Zhou L, Sun S, Wang B.
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1636-8. PubMed ID: 19139289
    [Abstract] [Full Text] [Related]

  • 28. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
    Brooks DE, Andrew SE, Dillavou CL, Ellis G, Kubilis PS.
    Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
    [Abstract] [Full Text] [Related]

  • 29. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
    Marangon FB, Miller D, Giaconi JA, Alfonso EC.
    Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
    [Abstract] [Full Text] [Related]

  • 30. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K, Tredup A, Salvenmoser S, Müller FM.
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [Abstract] [Full Text] [Related]

  • 31. Determination of MICs of aminocandin for Candida spp. and filamentous fungi.
    Isham N, Ghannoum MA.
    J Clin Microbiol; 2006 Dec; 44(12):4342-4. PubMed ID: 17021057
    [Abstract] [Full Text] [Related]

  • 32. In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis.
    Weinstein WL, Moore PA, Sanchez S, Dietrich UM, Wooley RE, Ritchie BW.
    Am J Vet Res; 2006 Apr; 67(4):562-8. PubMed ID: 16579746
    [Abstract] [Full Text] [Related]

  • 33. Activity of antibiotics against Fusarium and Aspergillus.
    Day S, Lalitha P, Haug S, Fothergill AW, Cevallos V, Vijayakumar R, Prajna NV, Acharya NR, McLeod SD, Lietman TM.
    Br J Ophthalmol; 2009 Jan; 93(1):116-9. PubMed ID: 18952649
    [Abstract] [Full Text] [Related]

  • 34. In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species.
    Clancy CJ, Nguyen MH.
    Eur J Clin Microbiol Infect Dis; 1998 Aug; 17(8):573-5. PubMed ID: 9796657
    [Abstract] [Full Text] [Related]

  • 35. Antifungal effect of ophthalmic preservatives phenylmercuric nitrate and benzalkonium chloride on ocular pathogenic filamentous fungi.
    Xu Y, He Y, Li X, Gao C, Zhou L, Sun S, Pang G.
    Diagn Microbiol Infect Dis; 2013 Jan; 75(1):64-7. PubMed ID: 23102555
    [Abstract] [Full Text] [Related]

  • 36. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
    Öz Y, Özdemir HG, Gökbolat E, Kiraz N, Ilkit M, Seyedmousavi S.
    Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
    [Abstract] [Full Text] [Related]

  • 37. Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.
    Spierer O, Dugar J, Miller D, OʼBrien TP.
    Cornea; 2015 May; 34(5):576-9. PubMed ID: 25826327
    [Abstract] [Full Text] [Related]

  • 38. Antifungal susceptibility profiles for fungal isolates from corneas and contact lenses in the United Kingdom.
    Tuft S, Stone NRH, Burton MJ, Johnson EM, Borman AM.
    Eye (Lond); 2024 Feb; 38(3):529-536. PubMed ID: 37684376
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.